MedTrace Logo

Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients

NCT03606616 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2022-10-18

No results posted yet for this study

Summary

In patients undergoing breast-conserving surgery and having positive sentinel lymph nodes (SLNs), the ACOSOG Z0011 trial showed equivalent overall survival(OS) and disease-free survival(DFS) outcomes for patients receiving SLN dissection (SLND) alone and those receiving axillary lymph node dissection (ALND). We conducted a prospective single-arm study to confirm the applicability of the Z0011 criteria to Chinese patients with breast cancer.

Conditions

  • Breast Cancer
  • Sentinel Lymph Node
  • Local Recurrence of Malignant Tumor of Breast

Interventions

PROCEDURE

no further ALND arm

Patients meeting the Z0011 inclusion criteria to receive no additional ALND

Sponsors & Collaborators

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • shu wang · Peking University People's Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03606616 on ClinicalTrials.gov